Literature DB >> 30951495

Sub-membranous actin rings in the axon initial segment are resistant to the action of latrunculin.

Amr Abouelezz1,2, David Micinski1, Aino Lipponen1, Pirta Hotulainen1.   

Abstract

The axon initial segment (AIS) comprises a sub-membranous lattice containing periodic actin rings. The overall AIS structure is insensitive to actin-disrupting drugs, but the effects of actin-disrupting drugs on actin rings lack consensus. We examined the effect of latrunculin A and B on the actin cytoskeleton of neurons in culture and actin rings in the AIS. Both latrunculin A and B markedly reduced the overall amount of F-actin in treated neurons in a dose-dependent manner, but the periodicity of actin rings remained unaffected. The insensitivity of AIS actin rings to latrunculin suggests they are relatively stable.

Keywords:  cell biology; neurobiology; neuron

Mesh:

Substances:

Year:  2019        PMID: 30951495     DOI: 10.1515/hsz-2019-0111

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  Tropomyosin Tpm3.1 Is Required to Maintain the Structure and Function of the Axon Initial Segment.

Authors:  Amr Abouelezz; Holly Stefen; Mikael Segerstråle; David Micinski; Rimante Minkeviciene; Lauri Lahti; Edna C Hardeman; Peter W Gunning; Casper C Hoogenraad; Tomi Taira; Thomas Fath; Pirta Hotulainen
Journal:  iScience       Date:  2020-04-12

2.  Radial contractility of actomyosin rings facilitates axonal trafficking and structural stability.

Authors:  Tong Wang; Wei Li; Sally Martin; Andreas Papadopulos; Merja Joensuu; Chunxia Liu; Anmin Jiang; Golnoosh Shamsollahi; Rumelo Amor; Vanessa Lanoue; Pranesh Padmanabhan; Frédéric A Meunier
Journal:  J Cell Biol       Date:  2020-05-04       Impact factor: 10.539

3.  Ultrastructure of the axonal periodic scaffold reveals a braid-like organization of actin rings.

Authors:  Stéphane Vassilopoulos; Solène Gibaud; Angélique Jimenez; Ghislaine Caillol; Christophe Leterrier
Journal:  Nat Commun       Date:  2019-12-20       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.